Obesity in the dog and cat
"A complete and balanced diet is one of the fundamental aspects to optimizing health and longevity in companion animals, yet obesity in dogs and cats is becoming a major problem. This book provides a comprehensive review of obesity in small animal medicine with clinical application to veterinar...
| Other Authors: | Cline, Martha G.,, Murphy, Maryanne,, EBSCOhost. |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Boca Raton, Florida :
CRC Press, Taylor & Francis Group,
[2019]
|
| Physical Description: |
1 online resource. |
| Subjects: |
Table of Contents:
- Cover; Half Title; Title Page; Copyright Page; Dedication; Contents; Preface; Editors; Contributors; 1. Epidemiology of small animal obesity; 1.1 Definition; 1.2 Prevalence and time trends; 1.3 Risk factors; 1.3.1 Animal-specific factors; 1.3.1.1 Genetics and breed; 1.3.1.2 Age; 1.3.1.3 Gender and neutering; 1.3.2 Human-specific factors; 1.3.2.1 Diet type and feeding method; 1.3.2.2 Physical activity; 1.3.2.3 Owner attitudes and household characteristics; 1.4 Conclusion; References; 2. Pathophysiology of obesity: Metabolic effects and inflammation mediators.
- 2.1 Balancing energy expenditure and intake2.1.1 Evolutionary theories of obesity; 2.1.2 Regulation of appetite and food intake; 2.1.2.1 Central regulation of appetite; 2.1.2.2 Peripheral regulation of appetite; 2.1.2.3 Hedonic (pleasure) control of appetite; 2.1.3 Mechanisms of energy expenditure and metabolic control; 2.2 Inflammatory effects of obesity; 2.2.1 Endocrine functions of adipose tissue; 2.2.2 Obesity and inflammation; 2.2.2.1 Local inflammation; 2.2.2.2 Systemic inflammation; 2.3 Role of the microbiome in obesity; 2.3.1 Gut microbiota and obesity.
- 2.3.2 Utility of the gut microbiota in obesity management2.3.2.1 Dietary strategies; 2.3.2.2 Nondietary strategies; 2.4 Conclusion; References; 3. Pathophysiology of obesity: Comorbidities and anesthetic considerations; 3.1 Introduction; 3.2 Obesity and life span; 3.3 Obesity paradox; 3.4 Endocrine disease; 3.4.1 Diabetes mellitus; 3.4.2 Canine diabetes mellitus; 3.4.3 Feline diabetes mellitus; 3.4.4 Hyperadrenocorticism; 3.4.5 Hypothyroidism; 3.4.6 Hyperlipidemia; 3.5 Cardiovascular and respiratory disease; 3.5.1 Congestive heart failure and cardiovascular disease; 3.5.2 Hypertension.
- 3.5.3 Collapsing trachea3.6 Renal and urinary disease; 3.6.1 Renal disease; 3.6.2 Urinary disease; 3.7 Orthopedic and neurologic disease; 3.7.1 Orthopedic disease; 3.7.2 Neurologic disease; 3.8 Neoplasia; 3.9 Anesthetic considerations; 3.9.1 Obesity-induced alterations in physiology; 3.9.1.1 Respiratory pathophysiology; 3.9.1.2 Cardiovascular pathophysiology; 3.9.1.3 Other organ dysfunction; 3.9.2 Pharmacological differences in obesity; 3.9.2.1 Drug absorption; 3.9.2.2 Drug distribution; 3.9.2.3 Drug metabolism and elimination; 3.10 Conclusion; References.
- 4. Evaluation of body composition to diagnose obesity4.1 Introduction; 4.2 Carcass analysis of body composition; 4.3 Imaging modalities to assess body composition; 4.3.1 Dual energy x-ray absorptiometry (DEXA); 4.3.2 Computer tomography (CT); 4.3.3 Magnetic resonance imaging (MRI); 4.4 Nonimaging-based modalities to assess body composition; 4.4.1 Deuterium oxide dilution technique; 4.4.2 Bioimpedance; 4.5 Estimating body composition in a clinical setting; 4.5.1 Body weight; 4.5.2 Morphometric measurements; 4.5.2.1 Body mass index (BMI); 4.5.2.2 Novel morphometric equations.